Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy With Tandem PBSC Rescue for High-Risk Pediatric Solid Tumors
NCT00179816Phase 2Unknown
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Apr 1999
- Primary completion
- Sep 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of etoposide, carboplatin, cyclophosphamide and melphalan in Ewing sarcoma, soft tissue sarcoma (STS), hepatoblastoma and 3 more, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Primary endpoint: Feasibility and Toxicity of Tandem PBSC Rescue. Status: unknown.
02
Drugs
etoposidecarboplatincyclophosphamidemelphalan
03
Conditions
Ewing sarcomasoft tissue sarcoma (STS)hepatoblastomaHodgkin lymphoma (HL)germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00179816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179816.